Literature DB >> 2180106

Time course of response to oral and inhaled corticosteroids in non-asthmatic chronic airflow obstruction.

D C Weir1, A S Robertson, R I Gove, P S Burge.   

Abstract

One hundred and twenty one patients considered on clinical grounds to have non-asthmatic chronic airflow obstruction completed a double blind, crossover trial comparing oral prednisolone 40 mg per day with inhaled beclomethasone dipropionate 500 micrograms thrice daily, each given for 14 days, with a 14 day washout period between treatments. The time course of response was analysed for the 57 occasions where there was a significant increase in mean daily peak expiratory flow (PEF) over the treatment period. Mean daily PEF was still rising at day 14 on 12 occasions. After withdrawal of treatment mean daily PEF remained above pretreatments levels for more than two weeks in half the responses analysed. The peak response occurred earlier with inhaled beclomethasone (median 9.5 (range 3-14) days) than with oral prednisolone (median 12 (range 1-14) days), though both treatments produced a response that was sustained for a similar period. The results suggest that a trial of treatment with corticosteroids in this group of patients should last more than 14 days, and that in a study with a crossover design the washout period should be longer than two weeks.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180106      PMCID: PMC462321          DOI: 10.1136/thx.45.2.118

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  A double-blind cross-over study of beclomethasone dipropionate in asthmatic patients with and without chronic bronchitis.

Authors:  S Mintz; I Broder; G Davies; A Leznoff; H Rostum; F Silverman
Journal:  Postgrad Med J       Date:  1975       Impact factor: 2.401

2.  Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma.

Authors:  T J Clark
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

3.  Effects of prednisolone in chronic airflow limitation.

Authors:  D M Mitchell; P Gildeh; M Rehahn; A H Dimond; J V Collins
Journal:  Lancet       Date:  1984-07-28       Impact factor: 79.321

4.  Response to oral corticosteroids in chronic airflow obstruction.

Authors:  W K Lam; S Y So; D Y Yu
Journal:  Br J Dis Chest       Date:  1983-04

5.  Assessment of steroid responsiveness in patients with chronic airflow obstruction.

Authors:  T C Stokes; J M Shaylor; J F O'Reilly; B D Harrison
Journal:  Lancet       Date:  1982-08-14       Impact factor: 79.321

6.  High doses of inhaled corticosteroids in unstable chronic asthma. A multicenter, double-blind, placebo-controlled study.

Authors:  S Salmeron; J C Guerin; P Godard; D Renon; M Henry-Amar; P Duroux; A Taytard
Journal:  Am Rev Respir Dis       Date:  1989-07

7.  A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response.

Authors:  S M Harding; S Freedman
Journal:  Thorax       Date:  1978-04       Impact factor: 9.139

Review 8.  Corticosteroids in chronic bronchitis and pulmonary emphysema.

Authors:  S A Sahn
Journal:  Chest       Date:  1978-03       Impact factor: 9.410

9.  Time course of response to prednisolone in chronic airflow obstruction.

Authors:  J Webb; T J Clark; C Chilvers
Journal:  Thorax       Date:  1981-01       Impact factor: 9.139

10.  Recovery of plasma corticotrophin and cortisol levels after three-week course of prednisolone.

Authors:  J Webb; T J Clark
Journal:  Thorax       Date:  1981-01       Impact factor: 9.139

View more
  5 in total

Review 1.  Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.

Authors:  S P Conway; A Watson
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.

Authors:  J B Wempe; D S Postma; N Breederveld; E Kort; T W van der Mark; G H Koëter
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

3.  Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.

Authors:  D C Weir; P S Burge
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

Review 4.  Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

Authors:  Ian A Yang; Melissa S Clarke; Esther H A Sim; Kwun M Fong
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

5.  A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.

Authors:  Surya P Bhatt; Mark T Dransfield; John R Cockcroft; Jie Wang-Jairaj; Dawn A Midwinter; David B Rubin; Catherine A Scott-Wilson; Courtney Crim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.